Nanoscale Cell Adhesion Ligand Presentation Regulates Nonviral Gene Delivery and Expression
- 8 December 2006
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 7 (1), 161-166
- https://doi.org/10.1021/nl062485g
Abstract
It is hypothesized that the nanoscale organization of cell adhesion ligands in a synthetic ECM regulates nonviral gene delivery. This hypothesis was examined with pre-osteoblasts cultured on substrates which present varied density and spacing of synthetic adhesion ligands. The levels of gene transfer and expression were increased with the density of adhesion ligands, but decreased with the spacing of ligands, due to changes in the cell growth rate. This study provides a material-based control point on the nanometer scale for nonviral gene based therapies.This publication has 24 references indexed in Scilit:
- Multi-scale modeling to predict ligand presentation within RGD nanopatterned hydrogelsBiomaterials, 2006
- Capturing complex 3D tissue physiology in vitroNature Reviews Molecular Cell Biology, 2006
- Artificial viruses: a nanotechnological approach to gene deliveryNature Reviews Drug Discovery, 2006
- Tissue Cells Feel and Respond to the Stiffness of Their SubstrateScience, 2005
- Design and development of polymers for gene deliveryNature Reviews Drug Discovery, 2005
- Towards safe, non-viral therapeutic gene expression in humansNature Reviews Genetics, 2005
- Mechanobiology and diseases of mechanotransductionAnnals of Medicine, 2003
- Gene Therapy Progress and Prospects: Nonviral vectorsGene Therapy, 2002
- Tissue engineering via local gene delivery:Advanced Drug Delivery Reviews, 2000
- A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epitheliaGene Therapy, 1997